Table: begin end state 1 33 non-cytoplasmic 34 57 transmembrane 58 87 cytoplasmic 88 110 transmembrane 111 115 non-cytoplasmic 116 133 transmembrane 134 176 cytoplasmic 177 199 transmembrane 200 218 non-cytoplasmic 219 238 transmembrane 239 244 cytoplasmic 245 266 transmembrane 267 280 non-cytoplasmic 281 303 transmembrane 304 340 cytoplasmic 341 361 transmembrane 362 395 non-cytoplasmic 396 418 transmembrane 419 436 cytoplasmic 437 457 transmembrane 458 462 non-cytoplasmic 463 480 transmembrane 481 505 cytoplasmic
Input: >WP_211240420.1 NCBI__GCF_000527155.1:WP_211240420.1 MNFLDEFGSKLEEWVNSATAPIEGVVSATSTFVWGPFLLIPLLLGAGIILTSALGGIQFR RLGYGLWLAFFKRHEARDTEGDISHYQALSVALAATVGVGNIGGVAAAFTLGGPGALFWM WITGLLGMATKYSEALLGVKYRTVNEHGEQSGGPQQYLTRGLADITYLSEPVKKRIGAIL GLSFAVFGVVASFGIGNALQSGNVSSAITGQWEGVDNSLVGIIMMVVAGLVILGGIKWIG RVTSLFVPFMIVLYIAGTLAVLILNIDQLGAALNSIFSDAFTGSSAVGGFVGAGIITVVR AGVARGIFSNESGLGTGGIAAAAAKTDAAPRQAMVSMTQTFIDTIIVVTLTGLTIAVTGV LGTERVNDDGETVMVEGADLTRLAFEEGLSGWGDAGGLIVALAVVLFAMSTIFGWSYYGE KCLERFAGDRFKLLYRTLFVLVVFVGAVTSLDVLWGISDVFNGLMAIPNLIGLIMLTPIL RKETSKFFSNRDWRLLPTDALEKNG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server